Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adult women aged 18 or older.
- People with a body mass index (BMI) between 35 and 39.99, plus at least one serious weight-related health condition — such as type 2 diabetes, high blood pressure, high cholesterol, sleep apnea, liver disease, acid reflux, asthma, severe urinary leakage, debilitating joint problems, or significantly reduced quality of life — OR a BMI of 40 or above.
- People who have received a tissue-based diagnosis (usually from an endometrial biopsy) confirming either early-stage (grade 1) uterine cancer or a pre-cancerous condition called endometrial intraepithelial neoplasia (EIN).
Who may not be able to join:
- People under 18 years of age.
- People with a BMI below 35.
- People who do not have a tissue-based diagnosis, or whose tissue diagnosis shows a more advanced uterine cancer (grade 2 or higher).
- People who are currently pregnant.
- People for whom bariatric (weight-loss) surgery would not be considered safe — this includes current smokers, people who have previously had bariatric surgery, people with active substance use issues, a recent suicide attempt, an eating disorder called bulimia nervosa, large abdominal hernias, or a psychiatric illness that is not well managed.
- People who are unable to read an English-language consent form, or who are unwilling to provide informed consent.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Colleen Feltmate, MD, Brigham and Women's Hospital
Phone: 617-732-8840
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
proportion of patients who schedule an appointment and speak with a surgeon 1-2 weeks after enrollment; proportion of patients who undergo the concurrent surgeries within 8 weeks of diagnosis (12 weeks for EIN patients)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.